Health Canada has approved cyclotron-produced technetium-99m, greenlighting the made-in-Canada technologyfor national implementation and opening the door toagreener, more reliableway to make the most commonly used medical isotope.
TRIUMF has announced a new research partnership with Ontario-based Fusion Pharmaceuticals to expand production and availability of actinium-225, a valuable but scarce radioisotope with tremendous promise as a cancer treatment.
Dr. Jess Brewer, a TRIUMF affiliate researcher and a member of the team that developed the laboratory’s Centre for Molecular and Material Sciences (CMMS), has been named a 2020 Fellow of the American Association for the Advancement of Science (AAAS)